Lars Stevens-Cullinane works in a dark room. But he's not processing negatives and printing photographs on light-sensitive ...

SKYRIZI® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug Agency (CDA-AMC) for inflammatory bowel diseases, initially for Crohn’s di ...

Psoriasis is a chronic, immune-mediated skin condition. It causes red, scaly, itchy, often inflamed patches. Because the ...

NoviThera ApS (“NoviThera”), a majority owned subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting Nordic ...

Codex Labs, a Silicon Valley skintech company, has launched KĀNGFÙ Cooling Recovery Gel, a game-changing skin-recovery ...

The epidemiology of psoriasis and cutaneous mycoses is scarce in Brazil. Thus, this cross-sectional study aimed to characterize the distribution of these diseases in Paraná. Data was obtained from the ...

A light-converting microneedle patch (EU-MN) delivers targeted intradermal UV phototherapy by releasing upconversion nanoparticles (UCNPs) and the photosensitizer MOP in response to skin conditions, ...

Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of Dermatology/National Psoriasis Foundation ...

Recent advances in molecular and pathobiology have brought the field of dermatology to the cusp of reaching a goal that seemed highly improbable or impossible just a few years ago: a cure for plaque ...

Intricate interactions between immune cells and cytokines define psoriasis, a chronic inflammatory skin condition that is immunological-mediated. Cytokines, including interleukins (ILs), interferons ...

If you have psoriasis, cold weather, dry air, and less exposure to sunlight can result in more flares during the winter months. Indoor heating may also dry out the skin, leading to psoriasis flares ...